Core Points - The company, Chongqing Taiji Industry (Group) Co., Ltd., was established on December 28, 1993, and is a publicly listed company since November 18, 1997, on the Shanghai Stock Exchange [3][4][9] - The registered capital of the company is RMB 556.890744 million [3][9] - The company's business philosophy focuses on health and wellness, aiming to become a leading enterprise in traditional Chinese medicine with a strong emphasis on innovation and technology [6][14] Company Structure - The company is a permanent joint-stock company, with the chairman serving as the legal representative [4][5] - The company has established a Communist Party organization to conduct party activities within the company [6][14] - The company’s senior management includes the general manager, deputy general managers, board secretary, and financial director [5][6] Business Scope - The company’s business scope includes the production and retail of pharmaceuticals, health food production, and various medical device manufacturing [6][7] - The company is also involved in research and development in medicine and technology, as well as agricultural products [7][8] Share Structure - The company has issued a total of 556.890744 million shares, all of which are ordinary shares [9][10] - The company can increase its capital through various legal means, including public offerings and employee stock ownership plans [10][11] - The company is restricted from repurchasing its shares except under specific circumstances, such as capital reduction or mergers [10][11] Shareholder Rights - Shareholders have rights to dividends, voting, and the ability to request meetings and propose agenda items [16][17] - Shareholders holding more than 3% of shares for over 180 days can request to review the company's financial records [17][18] - The company must provide legal opinions on the validity of shareholder meetings and decisions [26][27] Governance - The company’s board of directors is responsible for major decisions, including profit distribution and capital changes [24][25] - The company must hold annual shareholder meetings within six months after the end of the fiscal year [26][27] - The company has established procedures for calling and conducting shareholder meetings, ensuring transparency and compliance with legal requirements [28][29]

Group 1 - The 78th World Health Assembly will open on May 19, with China's delegation actively participating and sharing its contributions to global health governance [1][2] - China is committed to supporting the World Health Organization (WHO) in its central coordinating role in global health governance and aims to enhance the health interests of developing countries [1] - The assembly will review the draft of the "Pandemic Accord," which is of significant interest, and China will support WHO's leadership in global public health governance [1] Group 2 - China is integrating traditional medicine into its health system and promoting the fusion of traditional and modern medicine, collaborating with over 40 countries and regions [2] - The theme of the general debate at the World Health Assembly is "Creating a Healthy World," and China will host side events to share its experiences [2]